Latest filing published 15 Feb 2019 for Phio Pharmaceuticals Corp..
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +21.2%Entry US$3,960.00 · Close at T+365 US$4,800.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Keith L. Brownlie: trading record in brief
Keith L. Brownlie is a declared insider at 5 companies; the most frequent names are Soligenix, Inc., Phio Pharmaceuticals Corp. and Celldex Therapeutics, Inc. In total, 8 filings cover trades dated from 25 June 2013 to 13 February 2019.
On the market, this insider has only ever bought: 1 purchase, €15k in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 5 share grants and 2 option exercises.
The newest entry dates from 15 February 2019: a share grant, in Phio Pharmaceuticals Corp. The most recent open-market purchase was published on 26 June 2013, 4,884 days ago. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Keith L. Brownlie
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,000 shares0Common stockSEC:0001209191-19-010825:0
- 10,000 shares0Common StockSEC:0001209191-18-045458:0
- 10,000 sharesCommon Stock, par value $0.001 per shareSEC:0001179110-17-009169:0
- 14,286 shares@ US$0.61Common StockSEC:0001213900-15-002584:0
- 5,000 shares0Common Stock, par value $0.0001 per shareSEC:0000905718-14-000287:0
- 16,667 shares@ US$0.30Common StockSEC:0001213900-14-003482:0
- 300,000 sharesCommon StockSEC:0001208261-13-000002:0
- 19,047 shares@ US$1.05Common StockSEC:0001213900-13-003303:0Canonical exit: 23 Sept 2013 (T+90)
8 of 8 declarations
